Our regular readers will remember that we have commented on and off on the development of different types of system that (maybe) can be used to test for risk of cancer based on smell … an ability that has been clearly demonstrated among certain trained dogs and one of two electronic systems. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: breath, cancer, Diagnosis, risk, screening, smell | Leave a comment »
A newly published paper on the development of prostate cancer in patients of ≤ 55 years of age claims to have shown that
Using a newly-developed computer model, it is now possible to predict the course of the disease in individual patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, genomics, medicine, modeling, personalized, prognosis | 2 Comments »
Clifton Leaf is a cancer survivor. He is also the Editor-in-Chief of Fortune magazine. And he has long argued that we may not be making the most astute decisions about how we are trying to find “the best” and “the rightest” ways to diagnose, treat, and manage cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: Diagnosis, Prevention, risk, Treatment | 7 Comments »
The “game changer” statement above comes from an independent review of the potential value of gallium-86-labeled prostate-specific molecular antigen (68Ga PSMA) PET scanning in the evaluation of selected men with prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: Diagnosis, gallium-68, PET, prognosis, PSMA, scan, work-up | 4 Comments »
We know that cancer can affect the sleep patterns of many cancer patients. There is clear evidence that this can also occur among prostate cancer patients. With a single rather obvious exception, what is less clear is exactly why having prostate cancer may affect the sleep of prostate cancer patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: Diagnosis, sleep, survey | 6 Comments »
For those who are interested in this evolving topic, we recommend listening to Dr. Charles Ryan’s 16-minute-long discussion with Heather Cheng, MD, PhD, entitled “Genetic evaluation and counseling in prostate cancer treatment”. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, genetics, genomics, Management, PARP, risk | 3 Comments »
Your sitemaster has long argued that it is perfectly reasonable for many younger men diagnosed with low- and very low-risk forms of prostate cancer to be managed initially on active surveillance (despite reticence on the parts of many physicians and many patients). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, age, AS, Diagnosis, Management, surveillance | 2 Comments »
A relatively long article in the June 21 issue of US News & World Report discusses a series of topical issues related to the diagnosis and management of prostate cancer, including: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, Management, test, today, tomorrow | 1 Comment »
Someone asked the sitemaster yesterday about a new test for risk of prostate cancer called Prostac® and where he could access this. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: development, Diagnosis, NucleoBio, Prostac, risk, test | Leave a comment »
Something that most of us seem to have managed to “miss” at the American Urological Association (AUA) annual meeting in San Francisco in May was an update from Dr. Ian Thompson on the 25-year outcomes of the Prostate Cancer Prevention Trial (PCPT). It has the potential to be rather important! … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, finasteride, Prevention, risk | 17 Comments »
Newly published research in Nature Genetics has reported the identification of yet another 63 new variants in the human genome that increase risk for a diagnosis of prostate cancer in males. This takes the total number of such variants identified to date to something approaching 175. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, genetics, genomics, risk | 3 Comments »
In an incidentally timely manner, the May issue of Annals of Oncology carries a systematic review and meta-analysis of data on physical activity and risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk | Tagged: activity, Diagnosis, exercise, physical, Prevention, progression, risk | 1 Comment »
“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: active, cancer, Diagnosis, Management, proactive, risk, surveillance | 13 Comments »
First and foremost, we would like to thank Prof. Ghulam Nabi of the University of Dundee for providing us with a preprint of the full text of his team’s article on transrectal SWE within about 30 seconds of receiving our request! That’s a record! … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, elastography, risk, shear, transrectal, ultrasound, wave | Leave a comment »
Just this morning, the University of Dundee issued a media release that included the following statement:
an ultrasound process called shear wave elastography (SWE) has been shown to offer much greater accuracy and reliability in diagnosis of prostate cancer, while being a non-invasive and cheaper method than those currently used.
Filed under: Diagnosis, Risk | Tagged: detection, Diagnosis, elastography, shear, SWE, transrectal, wave | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 